Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

Similar articles for PubMed (Select 23615641)

1.

Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy.

Neubauer H, Ruan X, Schneck H, Seeger H, Cahill MA, Liang Y, Mafuvadze B, Hyder SM, Fehm T, Mueck AO.

Menopause. 2013 May;20(5):504-10. doi: 10.1097/GME.0b013e3182755c97.

PMID:
23615641
2.

The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells.

Neubauer H, Yang Y, Seeger H, Fehm T, Cahill MA, Tong X, Ruan X, Mueck AO.

Menopause. 2011 Aug;18(8):845-50. doi: 10.1097/gme.0b013e31820e5ac5.

PMID:
21532513
3.

Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells.

Schneck H, Ruan X, Seeger H, Cahill MA, Fehm T, Mueck AO, Neubauer H.

Gynecol Endocrinol. 2013 Feb;29(2):160-3. doi: 10.3109/09513590.2012.730572. Epub 2012 Nov 2.

PMID:
23116217
4.

Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1.

Zhou J, Yu Q, Chen R, Seeger H, Fehm T, Cahill MA, Mueck AO, Neubauer H.

Maturitas. 2013 Oct;76(2):129-33. doi: 10.1016/j.maturitas.2013.06.013. Epub 2013 Jul 12.

PMID:
23856385
5.

Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells.

Ruan X, Neubauer H, Yang Y, Schneck H, Schultz S, Fehm T, Cahill MA, Seeger H, Mueck AO.

Climacteric. 2012 Oct;15(5):467-72. doi: 10.3109/13697137.2011.648232. Epub 2012 Feb 15.

PMID:
22335423
7.

Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.

Chen FP, Chien MH, Chen HY, Huang TS, Ng YT.

Taiwan J Obstet Gynecol. 2013 Sep;52(3):365-73. doi: 10.1016/j.tjog.2012.09.038.

PMID:
24075375
8.

Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cells.

Ruan X, Schneck H, Schultz S, Fehm T, Cahill MA, Seeger H, Chen R, Yu Q, Mueck AO, Neubauer H.

Gynecol Endocrinol. 2012 Nov;28(11):863-6. doi: 10.3109/09513590.2012.671396. Epub 2012 Apr 12.

PMID:
22494101
10.

The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cells.

Krämer EA, Seeger H, Krämer B, Wallwiener D, Mueck AO.

Menopause. 2005 Jul-Aug;12(4):468-74. Epub 2005 Jul 21.

PMID:
16037763
11.

Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.

Seeger H, Wallwiener D, Mueck AO.

Gynecol Endocrinol. 2008 Oct;24(10):576-9. doi: 10.1080/09513590802288267.

PMID:
19012101
12.

Effects of short-term estradiol and norethindrone acetate treatment on the breasts of normal postmenopausal women.

Cheng G, Butler R, Warner M, Gustafsson JÅ, Wilczek B, Landgren BM.

Menopause. 2013 May;20(5):496-503. doi: 10.1097/GME.0b013e318276c4ea.

PMID:
23615640
13.
14.

New insight on a possible mechanism of progestogens in terms of breast cancer risk.

Neubauer H, Chen R, Schneck H, Knorrp T, Templin MF, Fehm T, Cahill MA, Seeger H, Yu Q, Mueck AO.

Horm Mol Biol Clin Investig. 2011 Apr 1;6(1):185-92. doi: 10.1515/HMBCI.2010.082.

PMID:
25961254
15.

Progesterone receptor membrane component 1: is metabolism integral to its function and what other steroids are involved?

Price T.

Menopause. 2013 May;20(5):486-7. doi: 10.1097/GME.0b013e318287f30e. No abstract available.

PMID:
23511707
16.

The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells.

Krämer EA, Seeger H, Krämer B, Wallwiener D, Mueck AO.

Eur J Obstet Gynecol Reprod Biol. 2006 Nov;129(1):77-83. Epub 2006 Feb 7.

PMID:
16460873
17.

Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells.

Courtin A, Communal L, Vilasco M, Cimino D, Mourra N, de Bortoli M, Taverna D, Faussat AM, Chaouat M, Forgez P, Gompel A.

Breast Cancer Res Treat. 2012 Jan;131(1):49-63. doi: 10.1007/s10549-011-1394-5. Epub 2011 Feb 19.

PMID:
21336598
19.
20.

Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.

Neubauer H, Adam G, Seeger H, Mueck AO, Solomayer E, Wallwiener D, Cahill MA, Fehm T.

Climacteric. 2009 Jun;12(3):230-9. doi: 10.1080/13697130802635637.

PMID:
19340614
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk